Literature DB >> 33239421

IRF3 Signaling within the Mouse Stroma Influences Sepsis Pathogenesis.

Erica L Heipertz1, Jourdan Harper1, Dinesh G Goswami1, Charlie A Lopez1, Jose Nellikappallil2, Ruben Zamora3, Yoram Vodovotz3, Wendy E Walker4,2.   

Abstract

IFN regulatory factor 3 (IRF3) is a transcription factor that is activated by multiple pattern-recognition receptors. We demonstrated previously that IRF3 plays a detrimental role in a severe mouse model of sepsis, induced by cecal ligation and puncture. In this study, we found that IRF3-knockout (KO) mice were greatly protected from sepsis in a clinically relevant version of the cecal ligation and puncture model incorporating crystalloid fluids and antibiotics, exhibiting improved survival, reduced disease score, lower levels of serum cytokines, and improved phagocytic function relative to wild-type (WT) mice. Computational modeling revealed that the overall complexity of the systemic inflammatory/immune network was similar in IRF3-KO versus WT septic mice, although the tempo of connectivity differed. Furthermore, the mediators driving the network differed: TNF-α, IL-1β, and IL-6 predominated in WT mice, whereas MCP-1 and IL-6 predominated in IRF3-KO mice. Network analysis also suggested differential IL-6-related inflammatory programs in WT versus IRF3-KO mice. We created bone marrow chimeras to test the role of IRF3 within leukocytes versus stroma. Surprisingly, chimeras with IRF3-KO bone marrow showed little protection from sepsis, whereas chimeras with IRF3-KO stroma showed a substantial degree of protection. We found that WT and IRF3-KO macrophages had a similar capacity to produce IL-6 and phagocytose bacteria in vitro. Adoptive transfer experiments demonstrated that the genotype of the host environment affected the capacity of monocytes to produce IL-6 during sepsis. Thus, IRF3 acts principally within the stromal compartment to exacerbate sepsis pathogenesis via differential impacts on IL-6-related inflammatory programs.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 33239421      PMCID: PMC7785686          DOI: 10.4049/jimmunol.1900217

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Clinical trial research in focus: rethinking trials in sepsis.

Authors:  David Grimaldi; Jean-Louis Vincent
Journal:  Lancet Respir Med       Date:  2017-08       Impact factor: 30.700

2.  Hospital deaths in patients with sepsis from 2 independent cohorts.

Authors:  Vincent Liu; Gabriel J Escobar; John D Greene; Jay Soule; Alan Whippy; Derek C Angus; Theodore J Iwashyna
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

3.  TLR9 and IRF3 cooperate to induce a systemic inflammatory response in mice injected with liposome:DNA.

Authors:  Wendy E Walker; Carmen J Booth; Daniel R Goldstein
Journal:  Mol Ther       Date:  2010-02-09       Impact factor: 11.454

Review 4.  Methods to Study the Innate Immune Response to Sepsis.

Authors:  Wendy E Walker
Journal:  Methods Mol Biol       Date:  2018

5.  Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.

Authors:  D G Remick; D E Newcomb; G L Bolgos; D R Call
Journal:  Shock       Date:  2000-02       Impact factor: 3.454

6.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

Authors:  Christian Meisel; Joerg C Schefold; Rene Pschowski; Tycho Baumann; Katrin Hetzger; Jan Gregor; Steffen Weber-Carstens; Dietrich Hasper; Didier Keh; Heidrun Zuckermann; Petra Reinke; Hans-Dieter Volk
Journal:  Am J Respir Crit Care Med       Date:  2009-07-09       Impact factor: 21.405

8.  Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18.

Authors:  James Lawrence Wynn; Chris S Wilson; Jacek Hawiger; Philip O Scumpia; Andrew F Marshall; Jin-Hua Liu; Irina Zharkikh; Hector R Wong; Patrick Lahni; John T Benjamin; Erin J Plosa; Jörn-Hendrik Weitkamp; Edward R Sherwood; Lyle L Moldawer; Ricardo Ungaro; Henry V Baker; M Cecilia Lopez; Steven J McElroy; Natacha Colliou; Mansour Mohamadzadeh; Daniel Jensen Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

9.  Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice.

Authors:  Hideyuki Yanai; Shiho Chiba; Sho Hangai; Kohei Kometani; Asuka Inoue; Yoshitaka Kimura; Takaya Abe; Hiroshi Kiyonari; Junko Nishio; Naoko Taguchi-Atarashi; Yu Mizushima; Hideo Negishi; Rudolf Grosschedl; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

10.  Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients.

Authors:  Giorgio Berlot; Michele Claudio Vassallo; Nicola Busetto; Margarita Nieto Yabar; Tatiana Istrati; Silvia Baronio; Giada Quarantotto; Mattia Bixio; Giulia Barbati; Roberto Dattola; Irene Longo; Antonino Chillemi; Alice Scamperle; Fulvio Iscra; Ariella Tomasini
Journal:  Ann Intensive Care       Date:  2018-12-10       Impact factor: 6.925

View more
  2 in total

1.  Aged IRF3-KO Mice are Protected from Sepsis.

Authors:  Dinesh G Goswami; Wendy E Walker
Journal:  J Inflamm Res       Date:  2021-11-03

Review 2.  STING1 in sepsis: Mechanisms, functions, and implications.

Authors:  Ruo-Xi Zhang; Rui Kang; Dao-Lin Tang
Journal:  Chin J Traumatol       Date:  2021-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.